Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Venous Thromboembolism × Cyclosporine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Multiple Myeloma 9 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Follicular 8 Leukemia, Myeloid, Acute 8 Burkitt Lymphoma 8 Lymphoma, Non-Hodgkin 7 Lymphoma, Mantle-Cell 7 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma 7 Leukemia, Myelomonocytic, Chronic 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Anemia, Refractory, with Excess of Blasts 6 Myelodysplastic Syndromes 5 Hodgkin Disease 5 Neoplasms, Plasma Cell 4 Lymphoma, Large-Cell, Anaplastic 4 Leukemia, Prolymphocytic 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Accelerated Phase 4 Leukemia 4 Recurrence 3 Primary Myelofibrosis 3 Myeloproliferative Disorders 3 Graft vs Host Disease 3 Dendritic Cell Sarcoma, Interdigitating 3 Congenital Abnormalities 3 Breast Neoplasms 3 Thrombocythemia, Essential 2

Interventions

apixaban 1 Tacrolimus 1 Gemcitabine 1 Fondaparinux 1 Drug Therapy 1 Cyclosporine 1 ALT-836 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03083782 2017-10-11

ACT

Thomas Jefferson University

Phase 1 Completed

Classical hematology

Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡